Business programme 2021

02 June 10:00–11:15
 Pavilion F, Healthy Life Area
Broadcast
Vitamin and Dietary Supplements Market: Russia Keeping Up with Global Trends
Panel session Session sponsored by RBC The issue of the conscious intake of vitamins and bioactive supplements has long been raised by both the medical community and the manufacturers of these drugs, who value their reputation and promote the idea of smart consumption. The coronavirus pandemic has served as sort of catalyst for this process, since many countries at the national level have realized the need for the vitamin fortification of the population.
Russia is no exception. Doctors share the opinion that the proper intake of vitamins and dietary supplements has a positive effect on the overall strengthening of a person’s immunity. Consumers’ attitude towards dietary supplements has also changed; polling has recorded increased consumer confidence in this group of drugs. The vitamin and mineral products market reacted instantly to the global trend: demand increased by 40% in 2020, as the market was worth around RUB 56 billion. This year, the situation is repeating itself. In January 2021, sales of vitamins and dietary supplements increased by 50% compared with last January.
The time has now come to think about how to fortify the population with vitamins. Is there a need for government policy with strict quality standards? Can we utilize the experience of the Soviet Union, where this work was carried out on a systematic basis? Who should think about the vitamin consumption culture and how? What steps should be taken to improve awareness-raising among the population on the proper intake of vitamins and dietary supplements?

Discussion topics:
• Global trends in vitamin fortification: is Russia keeping up?
• Growth in vitamin and dietary supplement sales in Russia and around the world – is this a global trend or a consequence of the pandemic?
• Whose job is it to enhance the culture of vitamin consumption?
• How can we ensure the availability of the highest quality vitamins and dietary supplements for the Russian market?
02 June 11:45–13:00
 Pavilion F, Healthy Life Area
Broadcast
Taking a National Healthcare to a Whole New Level: Creating Medical Ecosystems
Panel session Nowadays, success or failure of a medical institution is assessed depending on the quality of services it rendered. Finding a balance between usefulness to a specific patient, the use of leading treatment protocols and standards, and economic considerations is becoming top priority. That said, the volume of medical information in the world is doubled every 2.5 months. The term ‘digital healthcare’ is gradually fading out because absolutely all healthcare now works digitally. In these circumstances, it is not enough for a medical company to simply hire marketing or digital experts. What is needed is a union of separate industry players, each of which has a market niche, a wide store of skills, an organizational structure, and industry connections. Such a system must be fully integrated: on the level of communications, shared understanding of the specific character of the business, shared data, control processes, accounting and budgeting, and so on. Only in that case, such an ecosystem as Connected Health Enterprise can function as a single body.
● How will the growing ecosystem demand impact the balance of power on the market?
● Are we heading toward risks of monopolization?
● Is building ecosystems solely the privilege of the government and institutional players?
● Should we expect radical changes in the labour market?
● Is the current medical education system at risk of going out of date?
● Does international practice have answers to these questions?
Moderator:
Ivan Tyagoun — Head of Consulting, Head of Public Sector, KPMG in Russia and the CIS
Panellists:
Natalia Komarova — General Director, Rusatom Healthcare
Yury Krestinskiy — Chairman of the Board of Directors, Institute for Public Health Development; Vice President - Head of Healthcare Industry, Sberbank
Since 2016: head of research centre for economics and management in healthcare at the Skolkovo management school in Moscow. The centre's primary objective is to conduct research on effective management, economics and informational support for Russia's healthcare system and to create and implement educational programmes promoting development of professional healthcare managers. Since 2007: Director of Institute of Public Healthcare Development. Key recent project: Moscow Medical Cluster. 1993 foundation of the Bionika group, CEO. 2007: headed the Department of Pharmaceutical Activities, Regional and Information Policy at the Ministry of Health and Social Development of the Russian Federation. Apart from the activities covered by the name of the department, supervised development of high-tech medical care in the Russian Federation and engaged foreign specialists. Civil engagement: Since 2003: member of the coordinating council of the Russian Association of Pharmacy Chains. Since 1999: co-chairman of the coordinating council of the Russian Association for Pharmaceutical Marketing. 1995–2002: Association of Commercial Pharmaceutical Organizations PharmAsk, Deputy CEO. Works with the Institute of Public Healthcare Development and various professional committees under different government agencies. Has a versatile investment portfolio including projects in film, fitness (he is also an instructor in qigong and tai chi), fresh water supply, R&D of new medical products, venture projects, etc. Promotes young entrepreneurs. Has five children.
Oksana Monge — General Director, Sanofi Russia
Sergey Notov — President, MedInvestGroup
Born: 29 September 1973
Place of Birth: Kuybyshev, Novosibirskaya oblast, Russia
Marital status: married
Children: daughter

• In 1995 graduated from Tomsk State University, Faculty of Law.
• Business career started in Central City Hospital of Noyabrsk, as head of medical insurance department.
• 1999 – civil servant in Administration of Noyabrsk.
• 2005 - founded IPT Group.
• 2005 – Chairman of the Board, IPT Group.
• 2011 - Chairman of the Board at PAO «К+31», one of 25 top Russian medical centers in Russia according to RBC.
• 2016 - IPT Group rated by Pravo-300. IPT Group rated 21 among top Russian law firms.
• 2017 - IPT Group has been chosen as the winner of the 2017 Corporate Intl Magazine Global Award in 2 nominations ‘Pharmaceuticals & Life Sciences Law Firm of the Year in Russia’and “M&A Lawyer of the Year in Russia”.
Facts

• 2015 – FBO RIGA business jet hub successfully completed.
• 2015 – a complex project completed for conclusion of concession agreements aimed at creation of oncologic radiology centers in Moscow oblast.
• 2016 - private medical clinic “Petrovskiye Vorota” merged into the network of clinics «К+31», manages by IPT Group.
• 2016 - successful creation of the first Russian JV. The largest pharmaceuticals manufacturing localization project in Russia.
Airat Farrakhov — Deputy, Deputy Chairman of the Commission of the State Duma of the Federal Assembly of the Russian Federation for Support of the Development of Small- and Medium-sized Business
Work experience
State Duma of the Federal Assembly Russian Federation, Moscow, Russia:
Member of the State Duma VII convocation, committee on budget and taxes
• Chairman of the subcommittee on:
• Budget for the Russian pension fund
• Federal Fund for Compulsory Health Insurance
• Social Security Fund budget

Ministry of Finances of Russia, Moscow, Russia:
The Deputy Minister
• Budgetary activities in healthcare, civil sciences, culture, education, physical culture and sports, tourism, youth policy, pensions and social security for civilians, social insurance, employment; in the 2014 Olympic Winter Games in Sochi, the preparation and hosting of the 2018 FIFA World Cup.

Ministry of Health care of Russia, Moscow, Russia:
The Deputy Minister
• Healthcare industry finances (obligatory investments, federal and regional budget, private investments)
• Health care digitalization

Ministry of Health care of republic of Tatarstan, Kazan, Russia:
The Minister, member of government board of republic of Tatarstan
• Ensured an increase in the volume of high-tech medical care by three times, reduced the incidence of child morbidity and mortality, increased life expectancy due to a decrease in mortality
• Reformed the structure of medical care by optimizing inefficient medical organizations, restructuring the financial support for the program of state guarantees
Ildar Khayrullin — General Director, International Medical Cluster Foundation
Front row participants:
Sergey Bushnev — Deputy Development Director, Priorov Central Scientific Institute of Traumatology and Orthopaedics Federal State Budgetary Institution under the Ministry of Health of the Russian Federation
Herman Inozemtsev — General Director, Santens Group of Companies
Ivan Ozhgikhin — Senior Managing Director, Business Development Centre, RUSNANO Management Company; Chairman of the Board, Medical Technology Consortium
Ivan Ozhgikhin was born on June 6, 1976 in the city of Kurgan. In 1998 he graduated from the Kurgan State Agricultural Academy with a degree in Accounting and Audit. In 2004 he got a second higher education from the Ural Federal University named after the first President of Russia B.Yeltsin with specialization in Management.
In 2000 he began his career with OJSC "Production Association Ural Optical and Mechanical Plant named after E.S. Yalamov” as an economist. In 2013, he was approved in the position of Director of Shvabe-Moscow LLC.
In 2016, Ivan Ozhgikhin was appointed Deputy General Director of Shvabe Holding (Development of Sales, Marketing and Service Support Systems for Civil Products).
Ivan Ozhgikhin is a Corresponding Member of the Academy of Medical and Technical Sciences, President of the non-profit partnership "International Association of Developers, Manufacturers and Users of Medical Equipment".
Vladislav Sherstoboev — Chief Executive Officer, GK "Expert"
02 June 13:30–14:45
 Pavilion F, Healthy Life Area
Broadcast
Affordable Quality: Opportunities and Risks of Developing the Generics Market in Russia
Panel session Session sponsored by RBC Trust in a brand, price, quality. These are the key principles of success on any market and the pharmaceutical market is no exception. Boosting the availability and efficiency of drugs is one of the key national healthcare goals, which is precisely why the generics market in Russia is actively growing and developing.
Meanwhile, the share of generics on the pharmaceutical markets of Germany and the United Kingdom is as high as 75%, yet this figure is only 45% in Russia. How can this indicator be increased and how can we meet the demand for high-quality and affordable drugs in Russia?
The domestic generics market remains a promising and significant one for manufacturers, investors, and consumers, but there are some key regulatory issues in pricing, patent laws, and public procurements that need to be addressed to support the sustainable development of this market.

• What resources do companies need in order to develop the production of affordable drugs?
• What mechanisms can help come up with productive solutions when developing the generics market in Russia?
• How can the national healthcare system and the end-user benefit from the expansion of the generic drug line?
02 June 15:15–16:30
 Pavilion F, Healthy Life Area
Broadcast
Biotechnology Entrepreneurship. Can Unicorns Exist in Russia?
(Session sponsored by Skolkovo Innovation Centre) The pandemic has had a huge impact on transformation of biotechnological innovations. Russian scientists have already demonstrated their prowess to the global scientific and business communities when the first ever coronavirus vaccine Sputnik V was registered in August 2020. To become a ‘unicorn’ in biotechnology, a startup needs to offer the market an entirely new product or present a significant transformation of an existing one. In global practice, it is becoming common practice when biotechnological innovations are created in cooperation: science and market go for maximum partnership. Lately, large industrial corporations in Russia work together with biotechnology startups to create incubation and acceleration programmes for start-ups, tailored to the needs of the market. Using the opportunities provided by these accelerators, young scientists, guided by the industry, hone their entrepreneurial skills, develop innovative technologies under the auspices of medical clinics, learn to attract investment, and receive mentoring support from the experts.
● How can the existing start-ups be sustained in Russia, new ones grown, and what is needed to take Russian innovations to the international arena?
● What conditions need to be created for inflow of investment to biotechnological startups?
● What should the integration of government, universities, labs, and industrial partners be like?
● What do innovation startups focus on now?
Moderator:
Pekka Viljakainen — Advisor to the Chairman of the Board of Directors, Skolkovo Foundation; Chairman, Aii Capital
Mr. Pekka A. Viljakainen was born in Finland 1972. He studied engineering at the University of Technology in Lappeenranta. For 25 years worked as an ambassador between business executives and technology teams. He started as an entrepreneur in 1986, by establishing Oy Visual Systems Ltd. (1986-2004). His company was merged with TietoEnator in 2000. Mr. Viljakainen is widely known by his nickname, Bulldozer. The nickname was earned by his reputation and track record for handling very complex governance and political topics inside large international organizations. During his corporate carrier he acted as trusted advisor for CEO’s and chairman’s specializing for the transformation related to enterprise digitalization and HR.
After 26 years of his active Visual Systems-Tieto carrier, he left from operative roles on 2011 and focused to his non-profit leadership education project called www.nofear-community.com . Because of this he has been visiting speaker and advisor for several international corporations and faculties (like IMD Business School).
Since 2012 Mr Viljakainen is acting as senior advisor for the president of Skolkovo Foundation. Since that among other directions of work, he has been acting as a founder and advisor for several nationwide entrepreneurship programs in Russian Federation. Startup Tour Open Innovations 2013-2018 (over 85 cities of Russia and CIS) and international conference Startup Village 2013-2018. During those programs he has build a strong network of entrepreneurs, local governmental institutions as well as universities across Russia and abroad.
Mr Viljakainen is the member of Strategic Board of the Russian Postal Service and member of the Supervisory Board of PAO “Pochta Bank”. Chairman of the Board of ‘’Skolkovo – Venture Investments’’, Chairman of the Board “ZYFRA”.
Mr Viljakainen is also known as investor, business angel and advisor for several high-tech companies. Those activities are handled thru his family investment office called www.Aii.fi
He is also well known supporter and philanthropic for several areas related to education, classical music as well as several social projects. His hobbies are helicopter flying PPL(H), cross country skiing, weight lifting and triathlon.
Panellists:
Arkady Dvorkovich — Chairman, Skolkovo Foundation
Born on May 26, 1972 in Moscow.
In 1994 graduated from Moscow State University with a Master degree in economics.
1994-1997 – worked as an expert in the Expert Group of Russia’s Ministry of Finance.
1997-2000 - Head of the Economic Expert Group of Russia’s Ministry of Finance.
Since August of 2000 – Adviser of the Minister of Economic Development and Trade.
Since 2001 - Deputy Minister of Economic Development and Trade.
Since April of 2004 - Head of the Presidential Experts’ Directorate of the Presidential Executive Office.
Since May 13, 2008 - Aide to the President.
From May 13, 2008 to May, 21 2012 served as an aide to the President of the Russian Federation.
On December 31, 2009 according to the decree of the President Dmitry Medvedev entered the working group for creation of a detached territorial complex for research and development and further commercialization of the results.
On May 21, 2012 he was appointed the Deputy Prime-Minister of the Russian Federation.
May 2018 – appointed co-chair of the Skolkovo Foundation council.
In September 2018, he was appointed to a government commission on modernising Russia’s economy and innovative development.
The same month, he was appointed Chair of the Skolkovo Foundation.
Natalia Komarova — General Director, Rusatom Healthcare
Igor Korobko — Head of Science and Innovative Development of Health Department, Ministry of Health of the Russian Federation (online)
Dmitry Kudlay — General Director, Generium
MD, professor
Academic background
University: Medical University, Novosibirsk
Department and Qualification: General medicine, doctor
Professional background
1996 - 1999 – Director, the hospital of the Ministry of Internal Affairs, Novosibirsk
2000 - 2004 – Managing positions in Marketing & Promotion, Russian pharmaceutical industry
2004 - 2013 – Deputy General Director (Marketing & Promotion), PHARMSTANDARD (the largest Russian pharmaceutical company)
2013 - present – General director, GENERIUM
Membership and Awards
• Member of the Government Subcommittee on the Circulation of Medicines
• Member of the working group on the Eurasian Economic Commission drug market, MoH
• Member of the Expert Council for the Development of Pharmaceutical and Medical Industry, Ministry of Industry and Trade
• Member of European Respiratory Society
• Winner of the Russian Federation Government Award
Dmitry Kudlay is the author of more than 70 scientific articles in peer-reviewed Russian and foreign publications.
Sophie Park — Chief Strategy Officer, Bayer G4A (online)
Robert Scott — Head of Product & Portfolio, Novartis Biome (online)
Evgeny Shlyakhto — Director General, Almazov National Medical Research Centre; President, All-Russian Non-Governmental Organization "Russian Society of Cardiology"
Professor Evgeny Shlyakhto, Director General of the Almazov National Medical Research Centre, Academician of the Russian Academy of Science, President of the Russian Society of Cardiology, Fellow of the European Society of Cardiology, the American Heart Association, and the American College of Cardiology.
Professor Shlyakhto was born on June 29, 1954 in Pogar, the Bryansk region. He graduated from the Pavlov Medical University in Saint Petersburg in 1977 and became Doctor of Science in Medicine in 1992, Professor in 1994, Honored Russian Scientist in 2004, and Academician of the Russian Academy of Sciences in 2014.
Evgeny Shlyakhto has been the Director General of the Almazov National Medical Research Centre since 2001 and the President of the Russian Society of Cardiology since 2011. In 2010, he became a member of the WHO Expert Working Group.
The Centre led by Prof. Shlyakhto carries out intensive research in the fields of translational medicine, molecular diagnostics, development of diagnostic tools for personalized treatment, cellular and tissue engineering for therapeutic purposes, creation of biocompatible materials and tissue-engineered constructs designed to create breakthrough medical technologies of fundamental importance for providing high-tech care to patients with cardiovascular, endocrine and blood diseases.
The results of research work by Prof. Shlyakhto have been summarized in more than 800 publications, 16 inventions, 2 scientific discoveries, and a number of monographs. Prof. Shlyakhto was a supervisor in 57 PhD and 20 DSc students..
Professor Shlyakhto is a member of the Presidium of the Russian Academy of Science, the Presidential Council for Science and Education, the Regional Health Council under the Federation Council of the Russian Federal Assembly, the Expert Health Council of the Federation Council Committee on Social Policy of the Russian Federal Assembly, Vice President of the National Medical Chamber.
Evgeny Shlyakhto is the Editor-in-Chief of the following medical journals: Russian Journal of Cardiology, Translational Medicine, and Journal of Arrhythmology. He also is a member of the international editorial board of the European Heart Journal.
Professor Shlyakhto plays an active role in such international committees as the ESC Congress Programme Committee (since 2012) and of the ESC Committee for Practice Guidelines (since 2015).
Evgeny Shlyakhto received the Russian Federation Government Prize in science and technology in 2009 and won the Pavlov Award, the prize for scientific and technological achievement in Physiology and Medicine from the Saint Petersburg Government and St. Petersburg Scientific Center of the Russian Academy of Sciences, in 2011. He received an Order of Honour in 2012 and 4th class Order of Merit for the Motherland in 2017.
Front row participants:
Noor Jandali — Analyst, Droobi Health, Qatar
Sergei Sorokin — General Director, Intellogic LLC; Founder, Botkin.AI
Has more than 10 years of experience in the field of information technology in healthcare. As the director of the healthcare division in Rostelecom PJSC, S. Sorokin took part in the development of services within the Unified State Healthcare Information System of the Russian Federation and other healthcare IT projects in Russia and abroad.
Since 2015, he has been the founder and CEO of the Russian company Intellogic LLC, currently developing the TeleMD platform project for diagnosing diseases with use of artificial intelligence. The company utilizes a unique technology to build AI-based mathematical patient representation models, allowing doctors to analyze the risks of various diseases (including cancer) and to perform their early diagnostics and detection.
Vadim Tarasov — Director, Institute of Translational Medicine and Biotechnology
03 June 09:30–10:45
 Pavilion F, Healthy Life Area
Broadcast
Haemato-oncology: High-Quality Care and Access to Innovations
Panel session The Ministry of Health of the Russian Federation combined efforts with federal and regional healthcare organizers to achieve significant progress in providing high-quality medical care to patients with haemato-oncological diseases. Haemato-oncology is included in the Oncological Disease Management Federal Programme, national clinical recommendations, treatment protocols and standards are updated. Additionally, a unified digital outline is created to monitor the situation and to forecast the amount of medical care for patients, plus latest generation target drugs are gradually included in restrictive lists. According to leading federal centres and regional experts, in order to significantly increase the access to high-quality medical care for patients with haemato-oncological diseases today, additional focus is needed on the following aspects: increased financing, timely experience exchange among federal and regional experts, teaching regional healthcare experts and organizers the principles resource base usage (working with the digital outline, planning the needed volume of medical care). Also, when choosing the most effective treatment in addition to achieving the best clinical results considerations should include effective expenditure of budget resources.
● What are the perspectives for further improvement of clinical recommendations for treatment of haemato-oncological diseases (using CLL and AML as examples)?
● Is it possible to adjust approaches and principles of budget planning for treatment of patients, once there are target drugs with a fixed course of treatment?
● Has the level of availability of highly effective and innovative (target) treatments been updated since haemato-oncology was included in the Oncological Disease Management Federal Programme? (using CLL as an example)?
● What is in store in terms of organizational innovations in providing high-quality medical care to patients (creating a single management and succession care outline, using CLL as an example)?
● How will increased financing of 14 high-cost ICD codes impact availability of target treatments for patients with haemato-oncological diseases?
Moderator:
Aleksandr Petrov — Chairman of the Subcommittee on Circulation of Medicines, Development of the Pharmaceutical and Medical Industry of the Committee of the State Duma of the Russian Federation on Health Protection
Panellists:
Jerome Bouyer — Area Vice President–EEMEA, AbbVie (online)
Evgeny Kamkin — Deputy Minister of Health of the Russian Federation
Andrey Kaprin — Director, Federal State Budgetary Institution National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation
· Doctor of Medical Sciences, Professor, Academician of RAS, Honored Doctor of the Russian Federation.
· Director General of the National Medical Research Radiological Centre (NMRRC) of Ministry of Health of the Russian Federation, Director of the P.A. Herzen Moscow Cancer Research Institute, a branch of NMRRC.
· He is one of the leading specialists in the Russian Federation in the field of diagnosis and treatment of oncological diseases. Throughout the scientific and therapeutic activity, Andrey Kaprin conducts a purposeful development of modern methods of surgical and combined treatment of kidney, bladder, prostate and other localizations.
· Since 2014, Andrey Kaprin is heaing the first Russian scientific medical cluster in the field of oncology - the Federal State Budgetary Institution "National Medical Research Radiological Centre" of Ministry of Health of the Russian Federation, which was established on the basis of three leading medical centers - P. Herzen, A.Tsyb MRRC, and N. Lopatkin Research Institute of Urology and Interventional Radiology.
· At present, being the head of the NMRRC of Ministry of Health of the Russian Federation, being an academician of the Russian Academy of Sciences in oncoradiology, he supervises the development of nuclear medicine, radiology and radiotherapy in our country. He has taken charge of most complex and promising areas in the industry: the technical re-equipment of the radiation therapy departments of the regions, the creation of a program and a center for the development of contact methods of irradiation, the introduction and expansion of the first national medical proton center in the country, the introduction of modern methods of training specialists in radiology and radiotherapy, iIncluding telecommunication training and master classes in the regions, many of which are conducted by himself.
· Every year Andrey Kaprin performs over 300 complex surgical interventions for various oncological diseases.
· He has trained more than 300 doctors, including residents and graduate students. Under his leadership, 27 dissertations for the degree of candidate of medical sciences and 9 doctoral dissertations were prepared and successfully defended. The result of many years of hard work was the publication of more than 700 printed scientific works.
Dmitry Morozov — Deputy, Chairman of the Health Protection Committee, State Duma of the Federal Assembly of the Russian Federation
Valery Savchenko — General Director, National Medical Research Centre for Haematology Federal State Budgetary Institution under the Ministry of Health of Russia; Senior Independent Haematology Expert for the Ministry of Health of Russia (online)
Elena Chernyakova — Chairman, Federal Compulsory Medical Insurance Fund
Born on December 21, 1969 in the city of Kazan.

In 1997, she graduated from the Moscow State University of Commerce.
In 1991-1995 she worked as economist, accountant, chief accountant of production units of KAMAZ JSC.
In 1995-2001 she held the posts of deputy chief accountant, head of service, chief accountant of the Industrial Housing Maintenance Department of the city of Naberezhnye Chelny.
In 2001-2011, she was Deputy Chief Accountant of the Department of the Ministry of Construction, Architecture and Architecture of the Russian Federation. - From 2001 to 2011, she was Head of Department of the Ministry of Construction, Architecture and Housing and Communal Services of the Republic of Tatarstan, then Deputy Director of the Center for Economic and Social Research under the Cabinet of Ministers of the Republic.
In March 2011 she was appointed Deputy Director of the Department of Budget Policy and Methodology of the Ministry of Finance of the Russian Federation.
From 2011, she was Director of the Department of Information Resources of the Russian Ministry of Finance, then she headed the Department of Information Technology in the management of state and municipal finances and information support of the budget process of the Russian Ministry of Finance.
On March 13, 2020, she was appointed Chairperson of the Federal Compulsory Medical Insurance Fund, in accordance with Decree No. 600-r of the Government of the Russian Federation of March 13, 2020.
E. Chernyakova has the class rank of Acting State Counsellor of the Russian Federation, 3rd Class.
Awarded a medal of the Order "For Merit to the Fatherland" II degree. Holds a commendation from the President of the Russian Federation and the Minister of Finance of the Russian Federation. Also awarded with the Certificate of Merit of the President of the Russian Federation, the Certificate of Merit of the General Prosecutor of the Russian Federation, and the Medal "For Assistance to the Federal Tax Service" of the Federal Tax Service.
Holds a number of awards from federal and regional authorities of the Russian Federation.
Honored Economist of the Republic of Tatarstan.
Front row participants:
Sergey Voloshin — Head, Clinical Department of Chemotherapy of Hemoblastosis, Depression of Hematopoiesis, and Bone Marrow Transplantation, Russian Research Institute of Hematology and Transfusion Medicine, Federal Medical-Biological Agency (online)
Lilia Matveeva — President, Russian Society of Hematology "SODEJSTVIE" (online)
Irina Poddubnaya — Head of Department of Oncology and Palliative Care, Russian Medical Academy of Continuing Professional Education under the Ministry of Health of Russia (online)
Vadim Ptushkin — Senior Independent Haematology Expert, Deputy Chief Medical Officer for Haematology at Moscow City Haematology Centre of the Botkin Clinical City Hospital under Healthcare Department of Moscow, Doctor of Medicine, Professor (online)
03 June 11:15–12:30
 Pavilion F, Healthy Life Area
Broadcast
HIV: Innovative Solutions on the Road to Victory
Panel session The COVID-19 pandemic made healthcare all over the world transfer significant resources to fight the novel infection. However, it also intensified the prominence of infectious epidemics as a whole: today, HIV still takes millions of human lives. The medical community all over the world is working on finding innovative solutions that aside from stopping life-threatening infections, could also bring the patients back to a meaningful and comfortable life. Scientific research for preventing the spread of HIV has been marked by a number of breakthrough discoveries. Scientists have learned a lot about the genetic structure of the immune deficit virus and there is now a high probability of learning how to stop its spread. However, despite significant progress in treating HIV, development of an effective vaccine still remains a priority for the global scientific and medical community. Today, scientists in Russia and worldwide have made an important step forward in developing the vaccine; it may be that in the future these discoveries will be able to make humans resistant to the immune deficit virus.
● Will the experience of struggle against the SARS-CoV-2 virus become a spring board for explosive growth of scientific research in the fight against infectious epidemics, in particular, the HIV infection?
● What are the most advanced and ground-breaking scientific discoveries and innovative solutions in preventive immunization and HIV infection treatment these days in Russia and worldwide?
● Will the COVID-19 pandemic change the government strategy for fighting the spread of HIV infection and other socially significant diseases?
● What government policies will help stimulate development and manufacture of innovative drugs in Russia?
● What regulatory decisions can promote timely access of HIV patients to the therapy they need and to innovative therapeutic technologies?
● How can the effectiveness of measures to reduce the number of new HIV diagnoses and AIDS mortality be improved?
● Can one say that victory over socially significant infections is only a matter of time?
Moderator:
Elena Voytsekhovskaya — Anchor, Doctor Channel
Panellists:
Denis Godlevsky — Director, Regional Public Organization "AIDS, Statistics, Health" (online)
Oleg Gridnev — Deputy Minister of Health of the Russian Federation
Alexey Mazus — Chief External Expert in HIV of the Ministry of Health of the Russian Federation and Moscow Healthcare Department
Ruslan Malyuta — HIV/AIDS Specialist, UNICEF Regional Office for Eastern Europe and Central Asia (online)
Vladimir Nazarov — Director, Financial Research Institute of the Ministry of Finance of the Russian Federation
Vladimir Nazarov CSc (Econ.) is Director of the Federal State Budgetary Institution “Scientific-Research Institute of Finance”, member of the Russian Ministry of Finance College and member of the Expert Board under the Russian Government.
2004–2005: Junior Fellow at the Macroeconomics and Finance Division, Institute for the Economy in Transition.
2005–2007: headed the laboratory of fiscal federalism and subnational finance, Institute for the Economy in Transition.
2007–2012: headed the Academy of National Economy under the Russian Government.
Since 2013: Deputy Director, Science, Institute of Social Analysis and Forecast at RANEPA under the Russian President. Since 2013: Director, Financial Research Institute.
His academic interests include inter-budgetary relations (including development of methods for transfer distribution between regional and local budgets), reform of the public sector, developing methods for assessing the efficiency of regional and local authorities, direct taxes, pension reform and healthcare economics. He is included among the Top-100 reserve of public administration staff under the patronage of the Russian President.
Craig Williams — Vice-President, Head of ViiV International, ViiV Healthcare (online)
Sergey Tsivilev — Governor of Kemerovo Region- Kuzbass
03 June 15:00–16:15
 Pavilion F, Healthy Life Area
Broadcast
The Role of Women in a Healthy Society
Panel session The COVID-19 pandemic showed that a healthy and harmonious society is the best recipe to oppose global emergency challenges. Its members must be ready take responsibility for their own health and for that of others, as well as to become dedicated allies to their governments in the fight against epidemics. Attention to personal physical and mental health, a healthy lifestyle, giving up bad habits and developing responsibility and awareness of self as a person and citizen – all these aspects of a healthy civil society are integrated into society back at the stage of primary socialization carried out in the family. In the 21st century, a woman has an opportunity for all types of social roles, she is part of various social and economic processes. However, it is still a woman who is responsible for the healthy future of her children. That means that she can exert key influence on development of healthy life as a whole, which will subsequently lay the groundwork for creating productive behavioural patterns in a harmonious and flourishing society.
● How can the desire to become an ambassador of a healthy lifestyle in society be promoted in women? What tools for this do we already have and what tools need to be provided?
● How can the full-time involvement of women in the bringing-up process in the family be preserved without limiting her involvement in social, political or entrepreneurial activities? What programmes may promote this?
● Is there an opportunity for looking at global experience and studying successful practices of involving women in creating a healthy lifestyle in order to adopt them in the national environment?
● How much can the female community impact the stability of healthcare systems?
Moderator:
Anastasia Stolkova — First Deputy Director for Development, Roscongress Foundation
Panellists:
Sultana Afdhal — Chief Executive Officer, World Health Innovation Summit (WISH)
Oksana Drapkina — Director, National Medical Research Center for Preventive Medicine of the Ministry of Health of the Russian Federation
Doctor of medical Sciences, Professor, corresponding member of RAS
Oksana M. graduated from the MMA named after I. M. Sechenov in 1992. From 1992 to 1997 she worked in the intensive care unit of the clinic of internal diseases of MMA named after I. M. Sechenov. From 1997 to 2015 she worked at the Department of internal medicine propaedeutics First Moscow State Medical University named after I. M. Sechenov, where she was promoted from Department assistant to Professor. In 2013, she was Awarded the Russian government prize in the field of education. In 2017 she was appointed to the position of Director of "NMRC PM" of the Ministry of health of Russia.
Professor Drapkina combines ongoing clinical work with research activities.
Awards: diploma of the Ministry of health of Russia, Laureate of the Russian Government prize in education, badge " excellence in health care».
There were defended 16 PhD theses and 1 dissertation for the degree of doctor of medical Sciences under the scientific guidance of O. M. Drapkina, more than 600 scientific article were published in domestic and foreign journals, 7 monographs, 10 textbooks
Galina Karelova — Deputy Chairman of the Federation Council of the Federal Assembly of the Russian Federation
Deputy Chairperson of the Federation Council of the Russian Federation
Born on 29 June 1950 in the city of Nizhnyaya Salda, Sverdlovsk Region. In 1972, she graduated from the Sergei Kirov Urals Polytechnic Institute with a degree in engineering and economics. PhD in Economics and DSc in Social Sciences, professor. For 20 years she was engaged in teaching and research. Author of over 150 papers on economic, social and political issues.
Since 1990 – delegate, Deputy Speaker (1992–1993) of the Sverdlovsk Regional Parliamentarian Council.
1994–1996 – Deputy of the Council of Federation of the Federal Assembly of the Russian Federation, Chairperson of the Federation Council Committee on Social Policy.
1996–1997 – Deputy of the State Duma of the Federal Assembly of the Russian Federation, Chairman of the Subcommittee on International Humanitarian, Scientific and Cultural Cooperation of the State Duma Committee on International Affairs.
Since 1997 – Deputy and since 2000 – First Deputy Minister of Labour and Social Affairs of the Russian Federation.
April 2003 – March 2004 – Deputy Prime Minister of the Russian Federation on Social Affairs.
April 2004 – December 2007 – Chairperson of the Social Insurance Fund of the Russian Federation.
On 2 December 2007, she was elected a deputy to the Fifth State Duma, Deputy Speaker of the State Duma Committee on Budget and Taxes.
On 4 December 2011, she was elected a deputy to the Sixth State Duma, First Deputy Chair of the State Duma Committee on Labour, Social Policy and Veteran Affairs.
Since 22 September 2014, she is a Representative of the executive authority of the Voronezh Region in the Federation Council. Deputy Speaker of the Federation Council of the Federal Assembly of the Russian Federation, member of the Federation Council Committee on Social Policy. Initiator and drafter of more than 40 laws, including laws on social protection. Full State Counsellor 1st Class of the Russian Federation. Decorated with state orders and medals.
Ekaterina Pogodina — Director General, Johnson & Johnson Russia & CIS, Managing Director, Janssen, Pharmaceutical Division of Johnson & Johnson, Russia & CIS
Katerina began her career with Janssen in 2001, holding a number of positions in the Sales, Marketing and Market Access teams. She has been a member of the Russian board of directors since 2010 and was appointed Country Manager Russia in 2015, and then she was promoted to the position of Managing Director Russia & CIS in 2017. In April 2019 Katerina was appointed CEO of Johnson & Johnson Russia & CIS.
Throughout her 17-year career with Janssen, Katerina has consistently demonstrated high standards of quality and strong results. She led the launch of a whole range of new products and work across a number of therapeutic areas, as well as establishing several new business units. In her role as Commercial Operations Director, Russia, Katerina successfully led commercial teams in close collaboration with other departments, which yielded great business results and drove the company’s overall success.
Katerina graduated with distinction from the International University in Moscow, where she studied law. She also completed specialist education for senior executives at the London School of Economics and Political Science and Moscow School of Management Skolkovo.
Since 2015 Katerina has been a member of the board of directors of the Association of International Pharmaceutical Manufacturers (AIPM). Forbes magazine contributor, speaker of the Second Eurasian Women’s Forum.
Tatyana Yakovleva — First Deputy Head, Federal Medical-Biological Agency of the Russian Federation
Born 7 July 1960 in Goгky oblast.
In 1985, graduated Ivanovo State Medical Institute with honours, majoring in Paediatrics. Worked her way up from a rural hospital nurse to Chief Physician of Teykovo Central Regional Hospital (Ivanovo Oblast).
In 1999, elected Deputy of the 3rd State Duma of Ivanovo single member electoral district No.78 (Ivanovo oblast), also elected Deputy of the 4th, 5th, and 6th State Duma of the Federal Assembly of the Russian Federation.
Acted as Deputy Head of the State Duma Committee for Healthcare and Sports, Head of the State Duma Committee for Healthcare, First Deputy Head of the United Russia fraction at the State Duma of the Federal Assembly of the Russian Federation.
While in the State Duma, was a member of interagency working group on the Healthcare priority national project at the Russian Federation Presidential Council for the Implementation of the Priority National Projects, State Duma Committee for the Juvenile Affairs and Protection of their Rights and Governmental Committee for Combating Drug Abuse and Illegal Drug Trafficking, as well as acted as Deputy Head of State Duma Committee for Technical Regulation.
Doctor of Medicine, Honoured Doctor of the Russian Federation, Professor, co-author of over 59 research publications, 7 textbooks, 6 patents. The winner of the Russian Federation Governmental Award in the field of science and technology. In 2001, graduated Moscow State Social University specializing in Law. Holds top qualification category in Public Health. Chair of the Department on outpatient and social paediatrics at Pirogov Russian National Research Medical University (RNRMU), the Ministry of Health of the Russian Federation.
Decorated with the Order of Honour, Medal of the 2nd degree Order of Service to the Fatherland, Medal of Merit for the National Healthcare; received Citation from Valentina Matvienko, the Chair of the Federation Council of the Federal Assembly of the Russian Federation.
Appointed Deputy Minister of Healthcare of the Russian Federation by Government Order No.1010-р of 18 June 2012.
Front row participants:
Elena Aksenova — Director, Research Institute for Healthcare Organization and Medical Management of Moscow Healthcare Department
Elena Aksenova has been working at the Research Institute since December 2018.
Educated at Moscow State Pedagogical University, National Research University Higher School of Economics, Russian Presidential Academy of National Economy and Public Administration.
She worked as Vice-Rector for Development and Innovation at the I.M. Sechenov First Moscow State Medical University of the Russian Ministry of Health. She was Deputy Head of the Department of Innovative Development of Medical Science of RAMS, Head of the Expert Analytical Department of the Federal Agency for Scientific Organizations, Deputy Chief Scientific Secretary of the Presidium of the Russian Academy of Sciences.
Before assuming the position of Director of the Research Institute for Innovative Development of Medical Science of the DSMH, she was the Head of the Center for Strategic Planning of Science Development, Expertise and Scientific Advice of the RAS.
Maria Afonina — Vice Rector for Educational Activities of the Management Workshop "Senezh"
Natalia Darbinyan — Head of Communications, Support of Healthcare National Project, Natsionalnye Prioritety ANPO
Saniyam Koval — President, Podari Solnechny Svet Charitable Foundation
Olga Postnikova — Chief Executive Officer, Dobroe Delo Social Care Centre ANPO
Natalia Rodionova — Head of Head of devision, Healthcare Directorate, Roscongress Foundation
Olga Starikova — Deputy Head of National Project Support Division, Natsionalnye Prioritety ANPO
03 June 16:45–18:00
 Pavilion F, Healthy Life Area
Broadcast
High-Tech Medical Care: Expanding Access
Panel session Session sponsored by Vernoe Napravlenie ANPO Medical progress is dependent on complex and unique medical developments borne of modern scientific and technological breakthroughs. The recent significant changes to the healthcare funding system have affected the high-tech medical care sector as well. Now, federal medical organizations are directly funded through the Federal Compulsory Medical Insurance Fund. This means improved public access to high-tech medical care.
Additionally, the development of a federal system for telemedical consultations in recent years means that a person with a medical condition can get a consultation with a specialist in any federal medical organization. In practice, however, the public is ill-informed of the services available to them; the majority do not know about the possibility of remote consultations. Moreover, patients often have trouble getting a telemedical consultation due to existing bureaucratic barriers.
These factors greatly limit the access of a large part of the population to the full potential of the modern healthcare system, which creates reputational risks for the healthcare system as a whole and limits the system’s ability to provide the necessary volume of care.
● How can the regional residents be kept properly informed of new opportunities to receive medical care from federal medical organizations?
● What needs to be done to ensure the effective operation of the federal system of telemedical consultations? How can regional medical workers be kept in the loop?
● How is the telemedical consultation system organized in other countries? What best practices can be borrowed?
● What are the best regional practices for increasing access to medical care?
● How will the new changes affect the quality of medical care?
● Will pricing need to be adjusted?
Moderator:
Anton Yaremchuk — Deputy Director for Social Projects, Agency for Strategic Initiatives
Panellists:
Alexey Baindurashvili — Director, H. Turner National Medical Research Centre for Children’s Orthopaedics and Trauma Surgery Federal State Budgetary Institution under the Ministry of Health of Russia
Armais Kamalov — Director, University Clinic, Lomonosov Moscow State University; Head of the Urology and Andrology Department, Faculty of Fundamental Medicine, Lomonosov Moscow State University
Director of the Medical Research and Educational Centre of the Lomonosov Moscow State University, Head of the Urology and Andrology School of the Department of Fundamental Medicine of the Lomonosov Moscow State University, Academician of the Russian Academy of Sciences, Professor, Doctor of Medicine, Honoured Scientist of the Russian Federation.
The central focus of scientific research and practice:
Armais Kamalov’s scientific research focuses on urology, andrology and fundamental medicine. He is the author of many research papers, including monographs, textbooks, books, manuals, and patents for inventions. He is the author of many research papers, including monographs, textbooks, books, manuals, and patents for inventions. He was a scientific advisor of 5 doctoral and ten master’s theses. In 1992, he passed Candidate’s thesis defence, in 1998 – PhD thesis defence. Both focused on scientific rationale and introduction of radically new endoscopic methods of treatment of urological diseases.
Many years of scientific research and medical practice Armais Kamalov devoted to the development and implementation of high-tech minimally invasive methods of diagnosis and treatment of urological diseases, which significantly improved the outcome of treatment of many urological disorders.
In recent years, he has been devoting much attention to establishing a new medicine based on an interdisciplinary approach to solving men's health problems and improving reproductive health. Through his direct involvement, the organization of a programme to protect the health of the male population, including the setting up specialized medical clinics was successfully implemented in the regions of the Russian Federation.
Honours, awards
• Medal for Labour Valour (1997)
• Order of Honour 3rd Class (2006)
• Winner of the Prizvanie (Vocation) National Award ‘The Best Doctor of Russia’ nomination ‘For Breaking a New Medical Ground’ (2006)
• Lopatkin Award Winner ‘For the Contribution to the Development of Russian Urology’ (2007 & 2012)
• Medal ‘For Contribution to International Cooperation’ (2011)
• State Award ‘For Active Citizenship and Valuable Contribution to the Public and Political Life’
• Excellent Worker of Public Health (2012)
• Honoured Scientist of the Russian Federation (2016)
• Certificate of Appreciation ‘For Merit to the Urban Community’ (2019)
Armais Kamalov is a prominent scientist, teacher, top ranking urologist, who have mastered the most advanced treatment of urological diseases, a thought leader home and abroad. He is a well-regarded professional in public and professional communities.
Evgeny Kamkin — Deputy Minister of Health of the Russian Federation
Evgeniy Chekin — Deputy Chairman of the Government of of Kamchatka Territory
Evgeny CHEKIN is a graduate of Yaroslavl State Medical Academy and the All-Russian State Distance-Learning Institute of Finance and Economics
1995–1997 – Orderly at a rural first aid paramedic station
1997–1998 – Internship at Yaroslavl State Medical Academy
1998–2002 – Emergency room doctor
2002–2003 – Chief physician at a health and recreation resort
2003–2005 – Director of ANO Regional Foundation Centre
2005–2007 – Chief economist of the financial department, chief marketing operations manager, and senior credit expert at BINBANK
2007 – Director of a branch of RK Nomosleasing
2008–2009 – Executive Director of a standalone unit of VTB Leasing
2009–2011 – Head of the Public-Private Partnership Division of the Department of Economic Development of the Yaroslavl Region
2011–2012 – Head of the Public-Private Partnership Department of the Ministry of Economy and Industrial Policy of the Republic of Sakha (Yakutia)
2012–2016 – Deputy Minister of Economy of the Republic of Sakha (Yakutia).
2020 – Deputy Chairman of the Government of of Kamchatka Territory
Elena Chernyakova — Chairman, Federal Compulsory Medical Insurance Fund
Born on December 21, 1969 in the city of Kazan.

In 1997, she graduated from the Moscow State University of Commerce.
In 1991-1995 she worked as economist, accountant, chief accountant of production units of KAMAZ JSC.
In 1995-2001 she held the posts of deputy chief accountant, head of service, chief accountant of the Industrial Housing Maintenance Department of the city of Naberezhnye Chelny.
In 2001-2011, she was Deputy Chief Accountant of the Department of the Ministry of Construction, Architecture and Architecture of the Russian Federation. - From 2001 to 2011, she was Head of Department of the Ministry of Construction, Architecture and Housing and Communal Services of the Republic of Tatarstan, then Deputy Director of the Center for Economic and Social Research under the Cabinet of Ministers of the Republic.
In March 2011 she was appointed Deputy Director of the Department of Budget Policy and Methodology of the Ministry of Finance of the Russian Federation.
From 2011, she was Director of the Department of Information Resources of the Russian Ministry of Finance, then she headed the Department of Information Technology in the management of state and municipal finances and information support of the budget process of the Russian Ministry of Finance.
On March 13, 2020, she was appointed Chairperson of the Federal Compulsory Medical Insurance Fund, in accordance with Decree No. 600-r of the Government of the Russian Federation of March 13, 2020.
E. Chernyakova has the class rank of Acting State Counsellor of the Russian Federation, 3rd Class.
Awarded a medal of the Order "For Merit to the Fatherland" II degree. Holds a commendation from the President of the Russian Federation and the Minister of Finance of the Russian Federation. Also awarded with the Certificate of Merit of the President of the Russian Federation, the Certificate of Merit of the General Prosecutor of the Russian Federation, and the Medal "For Assistance to the Federal Tax Service" of the Federal Tax Service.
Holds a number of awards from federal and regional authorities of the Russian Federation.
Honored Economist of the Republic of Tatarstan.
Front row participant:
Ilya Buchkovsky — Member of the Board, Vernoe Napravlenie ANPO
04 June 10:30–11:45
 Pavilion F, Healthy Life Area
Broadcast
Healthy Life as a Path of Growth: Uniting All, Available to Each
Panel session The pandemic showed that responsible attitude to personal health is one of the basic values of a healthy society, which must have a high level of solidarity and resistance to the challenges of overwhelming disasters. A state must have sufficient potential so that in a force majeure it would have the resources to provide timely and effective medical care to patients with severe and chronic diseases, including cardiovascular diseases, malignant growths, diseases of the endocrine system, and others. The coronavirus crisis has become a vivid precedent of consolidation of the public and state in each other’s interests. By choosing the path of health protection, the public, on the one hand, helps the state to free up resources to provide up-to-date and high-quality medical care in all areas. On the other hand, the public prompts the creation of an effective infrastructure for healthcare activities, fulfilling the need for healthy living, strengthening of corporate health, and early diagnosis and disease prevention.
● Has the pandemic become an impetus to search for new development vectors in providing care to patients with socially significant diseases? How will the experience of the pandemic be reflected in the quality of such care in the future?
● What healthcare resources should the policy of creating a philosophy of responsible attitude to public health lean on?
● How can the culture of personal health awareness promote changes in present-day algorithms of medical care?
● What new areas in strengthening corporate and public health were created against the background of the pandemic?
● What measures of government policy should promote strengthening of prevention, early diagnosis, and PHC medical care?
● Will awareness of personal health and concomitant disease prevention become an effective measure in preventing the spread of severe diseases and creation of a healthy society?
Moderator:
Lika Kremer — Actress, TV-host
Panellists:
Oksana Drapkina — Director, National Medical Research Center for Preventive Medicine of the Ministry of Health of the Russian Federation
Doctor of medical Sciences, Professor, corresponding member of RAS
Oksana M. graduated from the MMA named after I. M. Sechenov in 1992. From 1992 to 1997 she worked in the intensive care unit of the clinic of internal diseases of MMA named after I. M. Sechenov. From 1997 to 2015 she worked at the Department of internal medicine propaedeutics First Moscow State Medical University named after I. M. Sechenov, where she was promoted from Department assistant to Professor. In 2013, she was Awarded the Russian government prize in the field of education. In 2017 she was appointed to the position of Director of "NMRC PM" of the Ministry of health of Russia.
Professor Drapkina combines ongoing clinical work with research activities.
Awards: diploma of the Ministry of health of Russia, Laureate of the Russian Government prize in education, badge " excellence in health care».
There were defended 16 PhD theses and 1 dissertation for the degree of doctor of medical Sciences under the scientific guidance of O. M. Drapkina, more than 600 scientific article were published in domestic and foreign journals, 7 monographs, 10 textbooks
Vitaliy Omelyanovskiy — General Director, Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation
Born July 27, 1964 in Obninsk, Kaluga Oblast.
In 1987, he graduated from the Pirogov Russian National Research Medical University with a degree in General Medicine. After graduation he stayed in the university, where he rose from postgraduate to professor of the department of clinical pharmacology.
In 1998 he graduated from the Russian Presidential Academy of National Economy and Public Administration of the Russian Federation with a degree in state and municipal management, with the qualification of economist-financier.
In 2002, he defended the first doctoral dissertation in the Russian Federation on clinical and economic analysis and pharmacoeconomics.
From 2009 to 2012 he was. - Vladimir Potanin was Director of the Research Institute for Clinical and Economic Expertise and Pharmacoeconomics at the N.I. Pirogov Russian National Research Medical University, Federal State Autonomous Educational Institution of Higher Professional Education, Ministry of Health Care of the Russian Federation.
From 2012 to 2020, she was Head of the Research Laboratory of the N.I. Pirogov Russian National Research Medical University. - Head of the Research Laboratory for Technology Assessment in Healthcare at the Institute of Applied Economic Research of the Russian Presidential Academy of National Economy and Public Administration, a federal state budget-funded educational institution of higher education.
Since 2014. - Head of the Healthcare Finance Center of the Federal State Budgetary Institution "Research Financial Institute" of the Ministry of Finance of the Russian Federation. Ministry of Finance of the Russian Federation.
Since 2015. - General Director of the Federal State Budgetary Institution "Center for Expertise and Quality Control of Medical Care" of the Ministry of Health of the Russian Federation.
Since 2020. - Head of the Department of Economics, Management and Assessment of Healthcare Technologies of the Federal State Budgetary Educational Institution of Additional Professional Education "Russian Medical Academy of Continuing Professional Education" of the Ministry of Healthcare of the Russian Federation.

Member of the Dissertation Council D 208.088.01.
Head of the Expert Council on Health Care of the Federation Council Committee on Social Policy, Expert of the Analytical Centre for the Government of the Russian Federation.
Chief Clinical Pharmacologist, Ministry of Health, Moscow Region.
Chief editor of scientific journals, Pharmacoeconomics. Modern Pharmacoeconomics and Pharmacoepidemiology" and "Medical Technology. Evaluation and Choice".
She is an author of three patents of the Russian Federation, two monographs, educational and methodical manuals for physicians, and more than 140 scientific papers published in Russian and foreign medical journals.
Doctor of Medicine (2002), Professor (2007). Under his supervision V.V. Omelyanovsky defended one doctoral thesis and seven Ph. Currently supervises the theses of two doctoral students and two doctoral candidates.
He is the President of the Russian branch of the International Society for Pharmacoeconomic Research and Outcome Evaluation (ISPOR).
He is a laureate of the Russian Federation Government Award in Science and Technology, has certificates of merit from the President of the Russian Federation and the Chairman of the Federation Council of the Federal Assembly of the Russian Federation, and has received commendations from the Chairman of the Federation Council of the Federal Assembly of the Russian Federation, the Analytical Center of the Russian Federation Government, the Russian Academy of National Economy and Public Administration under the President of the Russian Federation, and the Sverdlovsk Oblast Government.
Oleg Salagay — Deputy Minister of Health of the Russian Federation
Oleg Salagay, Candidate of Medical Sciences, Director of the Department of Public Health and Communications of the Ministry of Healthcare of the Russian Federation, Press Secretary of the Minister of Healthcare of the Russian Federation Veronika Skvortsova.
Born on 3 October 1983 in Irkutsk (Irkutsk Oblast).
In 2005, graduated with honours from Irkutsk State Medical University.
In 2006, graduated with honours from the Academy of Labour and Social Relations, Department of Law.
In 2010, graduated with honours from the Diplomatic Academy of Russian Foreign Ministry.
In 2011, received a Master’s Degree in European Law from Moscow State Institute of International Relations (MGIMO University) under the Ministry of Foreign Affairs of the Russian Federation.
Oleg Salagay is a member of many working groups under the auspices of the World Health Organization, BRICS, and bilateral cooperation. He is Chairman of the Conference of the Parties to the Framework Convention on Tobacco Control.
Niels Hessmann — General Director, Bayer; General Representative, Russia and CIS, Bayer AG
Niels Hessmann is the Managing Director of Bayer JSC and Senior Bayer Representative in Russia and CIS since March 1, 2015.
Niels Hessmann was born in Belgium and studied applied economic sciences at the University of Antwerp, Belgium. He began his career as a Market Research Manager in Schering (now Bayer) in Belgium in 1992.
In 1996, he headed the Marketing and Sales Department of Schering Romania and Moldova.
In 1999, he became the Managing Director of Schering Kazakhstan and was responsible for the company development in Central Asia.
In 2001, he was appointed the Managing Director of Schering Greece. In 2007, he headed Bayer Netherlands and was Bayer Healthcare Representative. During that period, Mr. Hessmann was also responsible for merging Bayer and Schering.
From November 2011 to February 2015, he was the Managing Director and Country Division Head Bayer HealthCare in South-Korea.
Evgeny Shlyakhto — Director General, Almazov National Medical Research Centre; President, All-Russian Non-Governmental Organization "Russian Society of Cardiology"
Professor Evgeny Shlyakhto, Director General of the Almazov National Medical Research Centre, Academician of the Russian Academy of Science, President of the Russian Society of Cardiology, Fellow of the European Society of Cardiology, the American Heart Association, and the American College of Cardiology.
Professor Shlyakhto was born on June 29, 1954 in Pogar, the Bryansk region. He graduated from the Pavlov Medical University in Saint Petersburg in 1977 and became Doctor of Science in Medicine in 1992, Professor in 1994, Honored Russian Scientist in 2004, and Academician of the Russian Academy of Sciences in 2014.
Evgeny Shlyakhto has been the Director General of the Almazov National Medical Research Centre since 2001 and the President of the Russian Society of Cardiology since 2011. In 2010, he became a member of the WHO Expert Working Group.
The Centre led by Prof. Shlyakhto carries out intensive research in the fields of translational medicine, molecular diagnostics, development of diagnostic tools for personalized treatment, cellular and tissue engineering for therapeutic purposes, creation of biocompatible materials and tissue-engineered constructs designed to create breakthrough medical technologies of fundamental importance for providing high-tech care to patients with cardiovascular, endocrine and blood diseases.
The results of research work by Prof. Shlyakhto have been summarized in more than 800 publications, 16 inventions, 2 scientific discoveries, and a number of monographs. Prof. Shlyakhto was a supervisor in 57 PhD and 20 DSc students..
Professor Shlyakhto is a member of the Presidium of the Russian Academy of Science, the Presidential Council for Science and Education, the Regional Health Council under the Federation Council of the Russian Federal Assembly, the Expert Health Council of the Federation Council Committee on Social Policy of the Russian Federal Assembly, Vice President of the National Medical Chamber.
Evgeny Shlyakhto is the Editor-in-Chief of the following medical journals: Russian Journal of Cardiology, Translational Medicine, and Journal of Arrhythmology. He also is a member of the international editorial board of the European Heart Journal.
Professor Shlyakhto plays an active role in such international committees as the ESC Congress Programme Committee (since 2012) and of the ESC Committee for Practice Guidelines (since 2015).
Evgeny Shlyakhto received the Russian Federation Government Prize in science and technology in 2009 and won the Pavlov Award, the prize for scientific and technological achievement in Physiology and Medicine from the Saint Petersburg Government and St. Petersburg Scientific Center of the Russian Academy of Sciences, in 2011. He received an Order of Honour in 2012 and 4th class Order of Merit for the Motherland in 2017.
Front row participants:
Yuriy Zhulev — President, Russian Hemophilia Society
In 1985, graduated from the school number 856 (Moscow).
In 1991, graduated from the Moscow State Law University.
In 1989, he was elected Vice President of Hemophilia Association (later renamed Hemophilia Society) that was established the same year.
Since 1993, he was the President of the Hemophilia Society.
In 2000, at the founding congress of the Russian Hemophilia Society he was elected its President, and he still holds this position.
In 2002–2004, he was a board member of the European Hemophilia Consortium and member of the World Federation of Hemophilia. He was named ‘Best volunteer’ of the World Federation of Hemophilia for his active work in CIS countries.
At present, he also holds the following positions:
• Co-chairman of the Russian Union of Patients Public Societies;
• Member of Commission for the Disabled under President of the Russian Federation;
• Head of the working group for improvement of the state sociomedical assessment system and monitoring of implementation of decisions made for the Commission for the Disabled under President of the Russian Federation;
• Co-chair of the Council of public agencies for patients’ rights for the Ministry of Health of the Russian Federation;
• Deputy Chairman of the Public Council of the Ministry of Health of the Russian Federation;
• Member of Council of public agencies for patients’ rights for Federal Service for Surveillance in Healthcare;
• Member of Moscow’s regional department of All-Russia People's Front.
Yury Zhulyov was awarded with an honorary certificate by the Ministry of Health of the Russian Federation, an honorary certificate by the Federal Service for Surveillance in Healthcare and Social Development.
Vadim Kukava — Executive Director, The Association of Pharmaceutical Companies «Innovative Pharma»
In 2012, Vadim Kukava was offered the position of Executive Director of the Association of leading global innovative pharmaceutical companies, InPharma. During this time, the Association has become a key player in the Russian pharmaceutical market, collaborating with government bodies to develop balanced regulations of the industry for the benefit of Russian patents.
From 2006 to 2012, Vadim worked in leading international companies that produce consumer goods, in positions connected to public/GR relations and policy affairs. During this time, Vadim participated in discussions on key legislation in the sphere of regulating the tobacco and medical industries, collaborated with representatives of the Russian and European scientific communities, and played an active role in the work of industrial associations, including on the Board. In addition, Vadim was responsible for creating and developing a division for public and regulatory affairs.
From 2004 to 2006, he worked as a consultant at the Federal Agency for State Property Administration (Rosimuschestvo). Vadim was responsible for implementing the full range of powers of ownership related to property within the forestry and chemical industry owned by the Russian Federation.
In 2003, he graduated from the Faculty of Law of the International University in Moscow.
04 June 12:15–13:30
 Pavilion F, Healthy Life Area
Broadcast
Present-Day Therapy Against Diabetes: Innovations for Improving the Quality of Life
Panel session The critical growth rate of diabetes and high risks of complications leading to disability and premature death require taking significant measures at the state level. One of the key objectives is ensuring that innovative treatment is available to the patients. Today, innovative sugar-lowering combination drugs are as revolutionary in treating type 2 diabetes as insulin was a hundred years ago. The issues of technological development, support and stimulus of research and development, clinical research and inclusion of new treatment schemas in clinical recommendations, and improvement of availability of modern drugs are quite critical and require federal support. Ensuring quick access to innovative treatment by the public is, among others, a matter of drug supply financing, expanding lists of benefits, creating patient registers, etc. In the long run, such measures will lead the practice of innovative drug supply to principles of individual approach to each diabetes patient.
● What steps need to be taken for innovative diabetes drugs to be produced in Russia in sufficient quantities?
● What needs to be done for patients to have access to modern drugs manufactured on international markets?
● What mechanisms and regulatory initiatives can stimulate the pharma industry to manufacture innovative drugs?
● What measures can promote increased availability of modern treatment?
● Will resuming the federal diabetes programme promote the goal of providing citizens with innovative treatment and in what way?
Moderator:
Elena Voytsekhovskaya — Anchor, Doctor Channel
Panellists:
Alexander Ametov — Head of Sub-department of Endocrinology of the Russian Medical Academy of Continuing Professional Education under the Ministry of Health of Russia
Elena Astapenko — Director, Department of Pharmaceutical Provision and Regulation of the Circulation of Medical Devices, Ministry of Health of the Russian Federation (online)
Dmitriy Galkin — Director of Department of Pharmaceutical and Medical Industry Development, Ministry of Industry and Trade of the Russian Federation (online)
Hans Duijf — Vice-President, Russia and Belarus, Novo Nordisk
Hans Duijf was appointed Vice President of Novo Nordisk in Russia and Belarus since September 1, 2017.
Mr. Duijf is a Dutch national, born in June 1974. He moved to Moscow with his family, wife and two daughters, from Colombia, where he held the position of General Manager of the Novo Nordisk affiliate since 2015.
Mr. Duijf has nearly 20 years of experience in the affiliates and regional headquarters of Novo Nordisk in established and developing markets in Europe, South-East Asia and Latin America. Under his leadership diverse teams of different cultures consistently succeeded in improving performance and introducing innovative approaches. Mr. Duijf began his career in sales and marketing in the UK, and later participated in the product launching in the markets of different countries. He has extensive management experience in positions such as Marketing Director, Business Development Director, General Manager, Vice President.
Hans Duijf has received education in international marketing and strategic management and holds a Master of Science (M.Sc.) degree in Business Administration from Rotterdam School of Management, Erasmus University in the Netherlands.
Yuriy Zhulev — President, Russian Hemophilia Society
In 1985, graduated from the school number 856 (Moscow).
In 1991, graduated from the Moscow State Law University.
In 1989, he was elected Vice President of Hemophilia Association (later renamed Hemophilia Society) that was established the same year.
Since 1993, he was the President of the Hemophilia Society.
In 2000, at the founding congress of the Russian Hemophilia Society he was elected its President, and he still holds this position.
In 2002–2004, he was a board member of the European Hemophilia Consortium and member of the World Federation of Hemophilia. He was named ‘Best volunteer’ of the World Federation of Hemophilia for his active work in CIS countries.
At present, he also holds the following positions:
• Co-chairman of the Russian Union of Patients Public Societies;
• Member of Commission for the Disabled under President of the Russian Federation;
• Head of the working group for improvement of the state sociomedical assessment system and monitoring of implementation of decisions made for the Commission for the Disabled under President of the Russian Federation;
• Co-chair of the Council of public agencies for patients’ rights for the Ministry of Health of the Russian Federation;
• Deputy Chairman of the Public Council of the Ministry of Health of the Russian Federation;
• Member of Council of public agencies for patients’ rights for Federal Service for Surveillance in Healthcare;
• Member of Moscow’s regional department of All-Russia People's Front.
Yury Zhulyov was awarded with an honorary certificate by the Ministry of Health of the Russian Federation, an honorary certificate by the Federal Service for Surveillance in Healthcare and Social Development.
Natalia Rudovich — Ассоциированный профессор, Медицинский Университет Цюриха; глава эндокринологического и диабетического подразделения департамента международной медицины, Больница Бюлах; член международного консультативного комитета, ФГБУ «Национальный медицинский исследовательский центр имени В.А. Алмазова» Минздрава России (online)
Oleg Ergashev — Vice-Governor of Saint Petersburg
04 June 16:30–17:45
 Pavilion F, Healthy Life Area
Broadcast
Medical Science. How to Expedite Introduction into Practical Healthcare
Panel session Session sponsored by Sechenov University Historically, Russian science has a strong systematic foundation and a unique potential focused on breakthrough discoveries, development of leading technologies, and implementation of innovative products that ensure preservation and improvement of people’s lives. Today, however, the volume of scientific results exceeds that of solutions introduced into practice: research and development do not always reflect the current needs of the public and are not always in demand by the healthcare system. Unfavourable factors for the growth of the Russian medical science include inter-departmental disconnectedness and low innovative activity of business. Thus, results of scientific achievements are poorly integrated into healthcare and a situation of lost opportunities for use of new drugs and technologies is created in society. Building a favourable environment for medical science is a strategic task of the national government policy growth. It starts with systematic analysis of practical healthcare needs, an expert evaluation of research and development, and goes all the way to building strategies for financing and introducing scientific achievements into the healthcare system. The year 2020 has given a special standing to international cooperation in development of medical science, setting the course toward sharing experience and looking for new growth paths, and that means restoring the status quo of Russian science among the leading global scientific countries.
● How well does the Strategy for the Development of Medical Science in the Russian Federation until 2025 correspond to the goals of strengthening the industry’s positions?
● Solution of which problems will promote the advancement of the level of fundamental and applicable scientific research and growth of the scientific human capital?
● How can innovative activity of Russian business be increased and the share of R&D in the national pharma industry enlarged?
● What state strategies should promote expedited introduction of scientific research results into practical healthcare?
● How can the process of integrating Russian medical science into the global science community be expedited?
Moderator:
Evelina Zakamskaya — Editor-in-Chief, Doctor Channel; Anchor, Russia 24
Evelina Zakamskaya was born on November 17, 1977, in Baku, and graduated from the Faculty of Philology at Tver State University. She is a presenter for Radio Mayak and for Mir, a television and radio company. Since 2006, she has been an anchor for television channel Russia 24. She writes and presents Mnenie (Opinion), a talk show covering social and political issues, and Idei, menyayushchie mir (World-Changing Ideas), a series of popular science programmes. Evelina Zakamskaya moderates Russia 24 sessions at major international forums. Since 2017 - Editor-in-Chief, Doctor Channel. She is married with two daughters.
Panellists:
Petr Glybochko — Rector, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation
Andrey Kaprin — Director, Federal State Budgetary Institution National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation
· Doctor of Medical Sciences, Professor, Academician of RAS, Honored Doctor of the Russian Federation.
· Director General of the National Medical Research Radiological Centre (NMRRC) of Ministry of Health of the Russian Federation, Director of the P.A. Herzen Moscow Cancer Research Institute, a branch of NMRRC.
· He is one of the leading specialists in the Russian Federation in the field of diagnosis and treatment of oncological diseases. Throughout the scientific and therapeutic activity, Andrey Kaprin conducts a purposeful development of modern methods of surgical and combined treatment of kidney, bladder, prostate and other localizations.
· Since 2014, Andrey Kaprin is heaing the first Russian scientific medical cluster in the field of oncology - the Federal State Budgetary Institution "National Medical Research Radiological Centre" of Ministry of Health of the Russian Federation, which was established on the basis of three leading medical centers - P. Herzen, A.Tsyb MRRC, and N. Lopatkin Research Institute of Urology and Interventional Radiology.
· At present, being the head of the NMRRC of Ministry of Health of the Russian Federation, being an academician of the Russian Academy of Sciences in oncoradiology, he supervises the development of nuclear medicine, radiology and radiotherapy in our country. He has taken charge of most complex and promising areas in the industry: the technical re-equipment of the radiation therapy departments of the regions, the creation of a program and a center for the development of contact methods of irradiation, the introduction and expansion of the first national medical proton center in the country, the introduction of modern methods of training specialists in radiology and radiotherapy, iIncluding telecommunication training and master classes in the regions, many of which are conducted by himself.
· Every year Andrey Kaprin performs over 300 complex surgical interventions for various oncological diseases.
· He has trained more than 300 doctors, including residents and graduate students. Under his leadership, 27 dissertations for the degree of candidate of medical sciences and 9 doctoral dissertations were prepared and successfully defended. The result of many years of hard work was the publication of more than 700 printed scientific works.
Vladimir Lazar — Chief Scientific and Operating Officer Worldwide Innovative Network Association - WIN Consortium (online)
Alla Samoylova — Head, Federal Service for Surveillance in Healthcare (Roszdravnadzor)
Born in Cheboksary.
1990: Graduated from the Chuvash State University named after I. N. Ulyanov with a degree in medicine.
2002: Awarded with the badge “Excellent Worker of Public Health”.
2007: Honored doctor of the Chuvash Republic.
2010: Doctor of Science in medicine.
2012: Professor of obstetrics and gynecology.
1987-1990 – nurse, obstetrician-gynecologist at the industrial hospitals in Cheboksary.
1990-1993 – Full-time postgraduate study at Chuvash State University.
1993-1994 - Assistant at the Obstetrics and Gynecology Department of the Chuvash State University.
1994-2012 – Chief Doctor of the Presidential Perinatal Center of the Ministry of Health and social development of the Chuvash Republic.
2010-2017 – Head of the Department of Obstetrics and Gynecology named after G. M. Vorontsova, of the Chuvash State University.
2012-2015 – Deputy Chair at the Cabinet of Ministers of the Chuvash Republic - Minister of Health and Social Development of the Chuvash Republic.
2015-2017 – Minister of Health of the Chuvash Republic.
2018-2019 – Adviser to the Head of the Federal Service for Surveillance in Healthcare.
2019-2020 – Head of the Department of State Control of Implementation of State Healthcare Programs, the Federal Service for Surveillance in Healthcare.
2020 – Director of the Project Activities Department, the Ministry of Health of the Russian Federation.
Since April 10, 2020 - Head of the Federal Service for Surveillance in Healthcare.
Tatyana Semenova — Deputy Minister of Health of the Russian Federation
Veronika Skvortsova — Head, Federal Medical-Biological Agency of the Russian Federation
Veronika Skvortsova was born in Moscow on November 1, 1960.
She graduated from the 2nd Pirogov Moscow State Medical Institute in 1983 and completed a Postgraduate Clinical Residency Programme and an Advanced Postgraduate Programme specializing in neuropathology. In 1994, she qualified as a higher category neurologist.
After graduating, she worked for the 2nd Moscow State Medical Institute (the Russian State Medical University since 1991) for 25 years.
Veronika Skvortsova became head of one of Russia’s first neurology emergency services at Moscow’s 1st municipal hospital established on the basis of the neurology clinic of the 2nd Moscow State Medical Institute in 1989.
In 1989–1995, she served as assistant and, in 1995–1997, as assistant professor at the Neuropathology Department of the Russian State Medical University.
She became Head of the Fundamental and Clinical Neurology and Neurosurgery Department in 1997.
Veronika Skvortsova was appointed Director of the Russian Stroke Research Institute in 2005.
She was Deputy Minister of Healthcare and Social Development from 2008 to 2012.
Veronika Skvortsova was appointed Minister of Healthcare by Presidential Executive Order No. 650 of May 21, 2012.
She is vice-president and co-founder of the National Stroke Association, director of the World Stroke Organization and secretary general of the European Stroke Council.
She is a Doctor of Medicine, Professor, and Corresponding Member of the Russian Academy of Medical Sciences.
Veronika Skvortsova is an Honored Scientist of the Russian Federation.
She has been awarded an Order of Honour and won the Pirogov Prize and Moscow Government Prize in Medicine.
She is the author of more than 400 research papers and holds seven patents for her inventions.
Shahrokh Shariat — Chairman, Department of Urology of the Medical University of Vienna (online)
Front row participants:
Dmitry Kudlay — General Director, Generium
MD, professor
Academic background
University: Medical University, Novosibirsk
Department and Qualification: General medicine, doctor
Professional background
1996 - 1999 – Director, the hospital of the Ministry of Internal Affairs, Novosibirsk
2000 - 2004 – Managing positions in Marketing & Promotion, Russian pharmaceutical industry
2004 - 2013 – Deputy General Director (Marketing & Promotion), PHARMSTANDARD (the largest Russian pharmaceutical company)
2013 - present – General director, GENERIUM
Membership and Awards
• Member of the Government Subcommittee on the Circulation of Medicines
• Member of the working group on the Eurasian Economic Commission drug market, MoH
• Member of the Expert Council for the Development of Pharmaceutical and Medical Industry, Ministry of Industry and Trade
• Member of European Respiratory Society
• Winner of the Russian Federation Government Award
Dmitry Kudlay is the author of more than 70 scientific articles in peer-reviewed Russian and foreign publications.
Simon Matskeplishvili — Deputy Scientific Director, Lomonosov Moscow State University Clinic; Member of the Board, Russian Society of Cardiology
Simon Matskeplishvili, MD, PhD, FESC, FACC, is a Professor of Cardiology and a Chief Scientific and Clinical Researcher at the Bakoulev Scientific Center for Cardiovascular Surgery in Moscow and an adjunct professor of life sciences at the Moscow Institute of Physics and Technology.
He also serves as a member of the Education, Certification and Accreditation, European Communities Committees of the European Association of Cardiovascular Imaging.
He graduated with honors from the Moscow Medical Academy in 1994 and had his postgraduate training and fellowship in cardiology at the Clinico-Diagnostic Department of the Bakoulev Center.
In 1997-1998 he received a degree of the International Master in Cardiology from the Institute of Clinical Physiology of the National Research Council of Italy in Pisa.
Simon Matskeplishvili is a Fellow of the European Society of Cardiology and a Fellow of the American College of Cardiology. He has received numerous honours and awards, both in Russia and internationally, including the European Cardiology award in 2001. He is a founder and a Chairman of the echocardiography section of the Russian society of cardiology. In 2007 he became a full professor of cardiology.
For the development of new non-invasive method of intracardiac blood flow evaluation in 2012 he was awarded a State Prize of the Government of Russian Federation in science and technology.
In 2013 he was a captain of the Russian team to win an ESC Cardiology Quiz “Primus inter pares” at the European Congress of Cardiology in Amsterdam.
In 2012 Professor Simon Matskeplishvili had organized and implemented the Educational Program for cardiologists and internal medicine physicians in Moscow. He also conducts an English-language elective course “Amazing Cardiology” in cardiology, cardiac surgery and cardiovascular imaging at the Faculty of Medicine of the Lomonosov Moscow State University.
The Board of the European Society of Cardiology has appointed Simon Matskeplishvili as the Coordinator of the Congress Programme Committee of the European Society of Cardiology Congress 2015-2016.
Vadim Merkulov — Deputy Director General for Drug Expertise, Scientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of the Russian Federation
Doctor of Medical Sciences, Professor of Molecular Biology
Deputy Director General for Drug Expertise, Scientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of the Russian Federation
Born in 1970 in Bryansk. In 1994, Dr. Merkulov graduated from Smolensk State Medical Institute. After graduation, he served in the Russian Armed Forces.
Scope of scientific interest:
Expert study of pharmaceuticals, molecular biology; molecular diagnostics of viral infections; research of antiviral agents using genetic engineering techniques; experimental immunology. Dr. Merkulov is a developer of diagnostic products for detection of several causative agents of particularly dangerous viral infections, as well as routine treatment for influenza. He authored more than 100 scientific papers and holds 9 patents.

Career:

• Dr. Merkulov held research positions while serving in the Russian Armed Forces.
• Since 2008: part-time Professor of the Department of Medical Nanobiotechnology at the Pirogov Russian National Research Medical University.
• 2010–2015: First Deputy Director General at the Scientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of the Russian Federation.
• Since 2015: Deputy Director General for Drug Expertise at the Scientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of the Russian Federation.
05 June 10:15–11:30
 Pavilion F, Healthy Life Area
Broadcast
Fostering a Health-Promoting Environment in the Context of Socioeconomic Development: New Challenges and New Solutions
Panel session Experience of the world’s leading countries confirms that investment in healthcare is the most effective strategy for economic growth. High level of public health and personal health of each citizen drives the economy. In 2020 the entire human race faced a global problem, the COVID-19 pandemic, which revealed to a large extent the unpreparedness of national economies and healthcare systems for dealing with new challenges. The solution of this problem requires carrying out innovative approaches at all management levels: globally, nationally, regionally, and municipally. Taking into account strategic national priorities, a wide discussion and implementation of a social model for improving public health at the regional and municipal level as a factor of long-term economic growth is very urgent and important.
● What is the role of municipal and regional governments in achieving maximum preparedness for new challenges in the public healthcare system?
● What measures at the regional level can improve public health, the quality of human capital, and promote constant economic growth?
● Can business be expected to become actively involved in systematic work on improving public health?
● What innovative practices and solutions are most effective?
Moderator:
Alexey Rashodchikov — Fund Co-chairman, City (Gorod) Moscow Centre of Urban Studies; Deputy Director for External Communications, Mosinzhproekt JSC
Panellists:
Melita Vujnovic — Representative to the Russian Federation, Head of Office, World Health Organization Office in the Russian Federation
Oksana Drapkina — Director, National Medical Research Center for Preventive Medicine of the Ministry of Health of the Russian Federation
Doctor of medical Sciences, Professor, corresponding member of RAS
Oksana M. graduated from the MMA named after I. M. Sechenov in 1992. From 1992 to 1997 she worked in the intensive care unit of the clinic of internal diseases of MMA named after I. M. Sechenov. From 1997 to 2015 she worked at the Department of internal medicine propaedeutics First Moscow State Medical University named after I. M. Sechenov, where she was promoted from Department assistant to Professor. In 2013, she was Awarded the Russian government prize in the field of education. In 2017 she was appointed to the position of Director of "NMRC PM" of the Ministry of health of Russia.
Professor Drapkina combines ongoing clinical work with research activities.
Awards: diploma of the Ministry of health of Russia, Laureate of the Russian Government prize in education, badge " excellence in health care».
There were defended 16 PhD theses and 1 dissertation for the degree of doctor of medical Sciences under the scientific guidance of O. M. Drapkina, more than 600 scientific article were published in domestic and foreign journals, 7 monographs, 10 textbooks
Oleg Kuvshinnikov — Governor of the Vologda Region
Mr. Kuvshinnikov was born in Cherepovets in 1965. He was actively involved in sport in his childhood and youth. He is a candidate master of sports in hockey. 1982 – Began working at Cherepovets Metallurgical Plant. 1985–1987 – Served in the Soviet Army. Military rank – sergeant. 1987 – Worked at Cherepovets Metallurgical Plant as the operator of the 250 Mill in the rolling shop. 1994 – Foreman of the rolling shop, then head of the 250 Mill and later deputy head of the production shop. 2000 – Head of the rolling shop. 2002 – Head of Sheet Rolling Shop No. 1. 2002–2006 – Deputy of the Cherepovets City Duma and Chairman of the Urban Affairs Committee. 2003 – Member of the United Russia party. 2004–2005 – Member of the Board of Directors of Severstal. 2004–2006 – Director of Social Amenities at Severstal. 2006 – First Deputy Mayor and acting Mayor of Cherepovets. 2007 – Elected Mayor of Cherepovets (65.3% of votes). 2007 – Member of the political council presidium of the Vologda regional branch of the United Russia party. December 2011 – Governor of the Vologda Region. May 17, 2014 – Acting Governor of the Vologda Region. September 23, 2014 – Elected Governor of the Vologda Region (62.98% of votes). Education: 1991 – Yaroslavl College of Soviet Trade. 1994 – St. Petersburg Trade and Economics Institute. 1999 – State University of Management in the ‘Production Management’ programme (Moscow). 2002 – Completed a training course in a corporate programme for the training of ‘Top 100’ managers. 2005 – Completed training in a MBA programme at the Academy of National Economy under the Russian Government.
Sergey Rybalchenko — General Director, Institute for Scientific Public Expertise; Deputy Chairman of the Commission on Support of Family, Children, and Motherhood, Civic Chamber of the Russian Federation
Mr. Rybalchenko is General Director of the Institute for Research and Community Expert Evaluation, head of the working group for social policy under the Russian Government Expert Board, member of the Community Council at the Russian Ministry of Labour and Social Protection, as well as the Russian Public Labour Board. He graduated from the Bauman Moscow State Technical School (1987) and from the postgraduate course of the National Research Institute Higher School of Economics (2010), Candidate of Economics.
1992 to 2006: worked in local government bodies and, since 2006, has been active in public and research work as an expert in strategic planning, family and demographic policy. He has authored 25 scholarly articles, including 4 monographs. The Institute for Research and Community Expert Evaluation serves as an umbrella for leading experts in family and demographic policies, performing expert evaluation of the regulatory impact of the legislation and managerial decisions.
Oleg Salagay — Deputy Minister of Health of the Russian Federation
Oleg Salagay, Candidate of Medical Sciences, Director of the Department of Public Health and Communications of the Ministry of Healthcare of the Russian Federation, Press Secretary of the Minister of Healthcare of the Russian Federation Veronika Skvortsova.
Born on 3 October 1983 in Irkutsk (Irkutsk Oblast).
In 2005, graduated with honours from Irkutsk State Medical University.
In 2006, graduated with honours from the Academy of Labour and Social Relations, Department of Law.
In 2010, graduated with honours from the Diplomatic Academy of Russian Foreign Ministry.
In 2011, received a Master’s Degree in European Law from Moscow State Institute of International Relations (MGIMO University) under the Ministry of Foreign Affairs of the Russian Federation.
Oleg Salagay is a member of many working groups under the auspices of the World Health Organization, BRICS, and bilateral cooperation. He is Chairman of the Conference of the Parties to the Framework Convention on Tobacco Control.
Front row participants:
Olga Vasilieva — CEO of Severgroup Medicine, Chairman of the Board of Directors of Scandinavia & Scandinavia AVA-Peter medical company, CEO of AVA-Peter medical company
Eames Guy — Chair, Green Building Council in Russia (RuGBC) Association for promotion and implementation of standards and rules of ecological construction (online)
Elvira Dovletyarova — Director of Agrarian and Technological Institute, RUDN University; Vice-president of the Russian Association of Landscape Designers (Moscow)
Elena Mikhailova — Coordination Council Member, Healthy Cities, Districts and Settlements Association for Public Health and Life Improvement
Ruslan Khalfin — Director, Higher School of Healthcare Management, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation
Ruslan Khalfin is Director of the Higher School of Healthcare Management at the I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation, a medical doctor, Professor, winner of a State Prize of the Russian Federation in the field of science and technology, Honoured Doctor of the Russian Federation, and Actual State Councillor of Russian Federation, 2nd class. He worked for more than 30 years in healthcare in the Sverdlovsk Region. He has also worked in the central office of the Ministry of Health of the Russian Federation and the Ministry of Health and Social Development of the Russian Federation, and has held the post of Deputy Minister under three federal ministers. He has been actively involved in reforming the sector, and was one of the originators and implementers of the national ‘Health’ project. For the past 11 years he has been President of the medical insurance company MAKS-M, part of the MAKS Insurance Group. Chair of the Board of the Russia-wide public organization ‘The Russian Association for the Organization of Health and Public Health’.
05 June 12:00–13:15
 Pavilion F, Healthy Life Area
Broadcast
Communications Ecosystem to Protect and Promote Health
Panel session Session sponsored by Natsionalnye Prioritety ANPO and Pirigov Russian National Reserch Medical University With the onset of the pandemic, it has become important as never before that the public receive up-to-date accurate information. Government efforts have been focused on development of various communication tools that allow reaching every person regardless of their age or location. Development of an open dialogue between the state, medical community, and the public has remained top priority to this day. In all the time of its existence, the image of healthcare has always encountered stereotypes, both positive and negative. Impartial healthcare indicators demonstrate systematic growth of the industry. However, it remains one of the most crisis-ridden ones in media space. Carrying out communication campaigns that focus on fighting chronic non-infectious diseases is incorporated into Healthcare and Demography national projects, whose key goal is to form a positive attitude of the country’s population toward development of national healthcare.
● What do popular opinion polls say? How do people feel about healthcare issues? Did the novel coronavirus infection pandemic impact the attitude of society toward healthcare?
● What difficulties does healthcare experience when working with media? Are there any special aspects? What communication channels should be stressed?
● How are healthcare communications with the public carried out at the regional and municipal levels?
● What are the salient features of Russian public healthcare communication campaigns as compared to foreign ones?
● What are the specifics of healthcare communication campaigns in social media? Which sites should have special attention?
Moderator:
Natalia Darbinyan — Head of Communications, Support of Healthcare National Project, Natsionalnye Prioritety ANPO
Panellists:
Melita Vujnovic — Representative to the Russian Federation, Head of Office, World Health Organization Office in the Russian Federation
Dmitry Komendantov — Government Relations Director, Mail.Ru Group
Aleksandra Malygina — Director of Communications, Healthcare Department of the Tyumen Region
Georgy Nadareishvili — Vice-Rector for strategic development, Pirigov Russian National Reserch Medical University, director, Federal center for volunteering and mentoring support in healthcare of the Ministry of health of Russian Federation
Oleg Salagay — Deputy Minister of Health of the Russian Federation
Oleg Salagay, Candidate of Medical Sciences, Director of the Department of Public Health and Communications of the Ministry of Healthcare of the Russian Federation, Press Secretary of the Minister of Healthcare of the Russian Federation Veronika Skvortsova.
Born on 3 October 1983 in Irkutsk (Irkutsk Oblast).
In 2005, graduated with honours from Irkutsk State Medical University.
In 2006, graduated with honours from the Academy of Labour and Social Relations, Department of Law.
In 2010, graduated with honours from the Diplomatic Academy of Russian Foreign Ministry.
In 2011, received a Master’s Degree in European Law from Moscow State Institute of International Relations (MGIMO University) under the Ministry of Foreign Affairs of the Russian Federation.
Oleg Salagay is a member of many working groups under the auspices of the World Health Organization, BRICS, and bilateral cooperation. He is Chairman of the Conference of the Parties to the Framework Convention on Tobacco Control.
Front row participants:
Julia Gryaznova — Head of Strategy, Analytics and Research Department, Natsionalnye Prioritety ANPO (online)
Victoria Madianova — Deputy Director, Higher School of Healthcare Leadership and Management, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation
05 June 13:45–15:00
 Pavilion F, Healthy Life Area
Broadcast
The Habit of Feeling Fit. How to Build Up Good Habits the Right Way?
Panel session Session sponsored by All-Russian Public Movement of Medical Volunteers The key goal of the Promoting Public Health National Project is to increase the number of citizens who follow a healthy lifestyle. Healthy lifestyle can be defined as a certain concept according to which a person is physically active, gives up bad habits, eats nutritiously, and looks after their mental health. The foundation for all rules of leading a healthy lifestyle is healthy habits, and a number of programmes and projects are being carried out among the public that help to build up and reinforce them. To organize successful work in this area, it is important to understand what methods of creating the right habits, approaches to the public, and formats of work to make a healthy lifestyle popular are most effective. Volunteer organizations that have their own projects focused on growing the public’s motivation to lead a healthy lifestyle are actively involved in helping make the healthy lifestyle popular. For effective and concerted work of volunteers and the government, it is important to realize what the focus needs to be when volunteers work with the public. It is important to understand which approaches to building healthy habits and developing the healthy lifestyle values are most effective, and what vectors there are for growth of volunteer activities in the healthy lifestyle area.
● What key principles of healthy lifestyle can be singled out and how does healthy lifestyle impact a person’s health?
● What are the basic ways of getting into good habits and how can one use them on their own? How can one help to build up good habits?
● What programmes and projects focusing on growing good habits among the public are carried out now?
● How does carrying out healthcare volunteer projects impact the commitment of the public to a healthy lifestyle?
● How does the Healthcare Generation Marathon of healthy lifestyle values impact the growth of good habits by the public?
Moderator:
Pavel Savchuk — Chairman, Russian Red Cross All-Russian Civic Organization
Panellists:
Natalia Darbinyan — Head of Communications, Support of Healthcare National Project, Natsionalnye Prioritety ANPO
Lyubov Drozdova — Senior Researcher, Department of Primary Prevention of Chronic Non-Infectious Diseases in the Healthcare System, FGBU State Scientific and Research Center for Preventive Medicine of the Ministry of Healthcare of the Russian Federation
Olga Kobyakova — Director, Federal Research Institute for Health Organization and Informatics of Ministry of Health of the Russian Federation (online)
Oleg Salagay — Deputy Minister of Health of the Russian Federation
Oleg Salagay, Candidate of Medical Sciences, Director of the Department of Public Health and Communications of the Ministry of Healthcare of the Russian Federation, Press Secretary of the Minister of Healthcare of the Russian Federation Veronika Skvortsova.
Born on 3 October 1983 in Irkutsk (Irkutsk Oblast).
In 2005, graduated with honours from Irkutsk State Medical University.
In 2006, graduated with honours from the Academy of Labour and Social Relations, Department of Law.
In 2010, graduated with honours from the Diplomatic Academy of Russian Foreign Ministry.
In 2011, received a Master’s Degree in European Law from Moscow State Institute of International Relations (MGIMO University) under the Ministry of Foreign Affairs of the Russian Federation.
Oleg Salagay is a member of many working groups under the auspices of the World Health Organization, BRICS, and bilateral cooperation. He is Chairman of the Conference of the Parties to the Framework Convention on Tobacco Control.
Zlata Chepurnaya — Member of Expert Panel for State Duma’s Physical Culture, Sports, Tourism and Youth Affairs Committee
Maria Yakunchikova — Chairman, All-Russian Public Movement of Medical Volunteers
Front row participants:
Zinaida Medvedeva — Executive Director, Healthy Nutrition (Zdorovoe Pitanie) National Research Centre
Mikhail Khors — Clinical psychologist, writer, TV host
Alexei Shavenzov — Senior Director, Government Affairs and Policy, Johnson & Johnson, Russia & CIS